You are here: Industry Insights > cardiovascular

News List

Discontinuing Statins Linked to Cardiac Admissions in Elderly drugs
August 05, 2019
For elderly patients taking statins for primary prevention, statin discontinuation is associated with an increased risk for admission for any cardiovascular even...
CIED Complication Rates Vary Considerably Among Hospitals drugs
July 31, 2019
Cardiovascular implantable electronic device (CIED) complication rates vary considerably among hospitals...
CV Event Risk Up With Rejected, Abandoned PCSK9i Prescriptions drugs
July 30, 2019
Patients with rejected or abandoned prescriptions for proprotein convertase subtilisin kexin type 9 inhibitors (PCSK9i) have a significantly increased risk...
Testosterone Replacement Therapy May Increase Cardiovascular Risk drugs
July 29, 2019
For aging men with low testosterone levels, testosterone replacement therapy (TRT) may increase the risk of cardiovascular events...
AHA News: Early Pregnancy May Be a Prime Time to Promote Heart Health drugs
July 24, 2019
Improving cardiovascular health during the early stages of pregnancy can lead not only to a healthier pregnancy...
People Living With HIV Have Higher Risk for Cardiovascular Disease drugs
July 19, 2019
People living with HIV (PLWH) have a higher risk for cardiovascular disease, according to a study published online in the?Journal of the American Heart Association.
Three Interventions Could Cut Cardiovascular Deaths drugs
June 28, 2019
Three Interventions Could Cut Cardiovascular Deaths.
Job cuts limit cardiovascular and diabetes research and development europeanpharmaceuticalreview
June 26, 2019
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Full data from CAROLINA? outcome trial support long-term cardiovascular safety profile of Trajenta? worldpharmanews
June 20, 2019
Full data from CAROLINA? outcome trial support long-term cardiovascular safety profile of Trajenta?.
ADA: Dulaglutide Tied to Decline in Cardiovascular Events in T2DM drugs
June 12, 2019
Dulaglutide Tied to Decline in Cardiovascular Events in T2DM.